Papers - KIYOI, Hitoshi
-
Immunoglobulin variable region structure and B cell malignancies. Reviewed
Kiyoi H, Naoe T.
Int J Hematol Vol. 73 page： 47 2001
-
Prognostic significance of the cell cycle inhibitor p27Kip1 in acute myeloid leukemia.
Leukemia Vol. 14 page： 28-33 2000
-
Leukemia relapse reconsidered from the molecular aspect.
Leukemia and Lymphoma Vol. 37 page： 527-534 2000
-
Histone deacetylase inhibitor but not arsenic trioxide differentiates acute promyelocytic leukaemia cells with t(11;17) in combination with all-trans retinoic acid.
Br J Haematol Vol. 108 page： 696-702 2000
-
Identification of a novel putative Ran-binding protein and its close homologue
Biochem Biophys Res Commun Vol. 278 page： 241-249 2000
-
Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related leukemia/ myelodysplastic syndrome and de novo acute myeloid leukemia. Reviewed
Clin Cancer Res Vol. 6 page： 4091-4095 2000
-
Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines. Reviewed
Hayakawa F, Towatari M, Kiyoi H, Tanimoto M, Kitamura T, Saito H, Naoe T.
Oncogene Vol. 19 page： 624-631 2000
-
Prognostic value of p53 gene mutations and the product expression in de novo acute myeloid leukemia.
Eur J Haematol Vol. 65 page： 23-31 2000
-
In vivo treatment of mutant FLT3-transformed murine leukemia with a tyrosine kinase inhibitor.
Leukemia Vol. 14 page： 374-378 2000
-
Poor clinical significance of p53 gene polymorphism in acute myeloid leukemia.
Leuk Res Vol. 24 page： 349-352 2000
-
Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis. Reviewed
Kitamura K, Minami Y, Yamamoto K, Akao Y, Kiyoi H, Saito H, Naoe T.
Leukemia Vol. 14 page： 1743 2000
-
Review of the immunoglobulin light chain variable region sequences from multiple myeloma cells.
Leukemia Vol. 13 page： 829-830 1999
-
Accurate quantitation of residual tumor burden at bone marrow harvest predicts timing of subsequent relapse in patients with common ALL treated by autologous bone marrow transplantation. Nagoya BMT Group.
Bone Marrow Transplant Vol. 24 page： 777-784 1999
-
Histone deacetylase inhibitors are the potent inducer/enhancer of differentiation in acute myeloid leukemia: a new approach to anti-leukemia therapy.
Leukemia Vol. 13 page： 1316-1324 1999
-
Molecular evolution of acute myeloid leukaemia in relapse : unstable N-ras and FLT3 genes compared with p53 gene.
Br J Haematol Vol. 104 page： 659-664 1999
-
Lack of constitutive activation of MAP kinase pathway in human acute myeloid leukemia cells with N-Ras mutation.
Leukemia Vol. 13 page： 585-589 1999
-
Etoposide-realted acute promyelocytic leukemia.
Leukemia Vol. 12 page： 1171-1175 1998
-
Differential constitutive activation between STAT-related proteins and MAP kinase in primary acute myelogenous leukaemia.
Br J Haematol Vol. 101 page： 521-528 1998
-
Characterization of the immunoglobulin light chain variable region gene expressed in multiple myeloma.
Leukemia Vol. 12 page： 601-609 1998
-
Prognostic significance of TEL/AML1 fusion transcript in childhood B-precursor acute lymphoblastic leukemia.
J Pediatr Hematolo/oncolo Vol. 20 page： 190-195 1998